Abstract
The sensitivities of the serum and bronchoalveolar lavage galactomannan (GM) assays in 48 patients with pulmonary aspergilloma were 38% (13 of 34; 95% confidence interval [CI], 22%-56%) and 92% (33 of 36; 95% CI, 78%-98%), respectively. The positivity of serum GM assays was significantly higher in patients with hemoptysis than in those without hemoptysis (52% vs 9%; P=.02).
| Original language | English |
|---|---|
| Pages (from-to) | e149-e152 |
| Journal | Clinical Infectious Diseases |
| Volume | 52 |
| Issue number | 7 |
| DOIs | |
| State | Published - 1 Apr 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver